BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 30558490)

  • 1. Elderly Patients with Advanced Head and Neck Carcinoma: Does Aggressive Treatment Result in Better Outcomes?
    Jang IJH; Skanthakumar T; Tan HK; Tan NC; Soo KC; Iyer NG
    Otolaryngol Head Neck Surg; 2019 Apr; 160(4):642-650. PubMed ID: 30558490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Outcome and prognostic factors of 125 loco-regionally advanced head and neck squamous cell carcinoma treated with multi-modality treatment].
    Qian W; Zhu G; Ji Q; Guo Y; Wang Y; Wang Y
    Zhonghua Zhong Liu Za Zhi; 2014 Mar; 36(3):217-22. PubMed ID: 24785284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiotherapy potentiation with weekly cisplatin compared to standard every 3 weeks cisplatin chemotherapy for locoregionally advanced head and neck squamous cell carcinoma.
    Fayette J; Molin Y; Lavergne E; Montbarbon X; Racadot S; Poupart M; Ramade A; Zrounba P; Ceruse P; Pommier P
    Drug Des Devel Ther; 2015; 9():6203-10. PubMed ID: 26648696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary tumor volume is an important predictor of clinical outcomes among patients with locally advanced squamous cell cancer of the head and neck treated with definitive chemoradiotherapy.
    Strongin A; Yovino S; Taylor R; Wolf J; Cullen K; Zimrin A; Strome S; Regine W; Suntharalingam M
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1823-30. PubMed ID: 21549516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of squamous cell carcinoma of external auditory canal: A tertiary cancer centre experience.
    Gandhi AK; Roy S; Biswas A; Raza MW; Saxena T; Bhasker S; Sharma A; Thakar A; Mohanti BK
    Auris Nasus Larynx; 2016 Feb; 43(1):45-9. PubMed ID: 26165629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of basaloid squamous cell carcinoma in head and neck cancer.
    Linton OR; Moore MG; Brigance JS; Gordon CA; Summerlin DJ; McDonald MW
    JAMA Otolaryngol Head Neck Surg; 2013 Dec; 139(12):1306-11. PubMed ID: 24158536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concurrent cetuximab and postoperative radiation in resected high-risk squamous cell carcinomas of the head and neck: A single-institution experience.
    Araki D; Redman MW; Martins R; Eaton K; Baik C; Chow L; Goulart B; Lee S; Santana-Davila R; Liao J; Parvathaneni U; Laramore G; Futran N; Mendez E; Bhrany A; Rodriguez CP
    Head Neck; 2016 Sep; 38(9):1318-23. PubMed ID: 27061333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer.
    Argiris A; Stenson KM; Brockstein BE; Mittal BB; Pelzer H; Kies MS; Jayaram P; Portugal L; Wenig BL; Rosen FR; Haraf DJ; Vokes EE
    Head Neck; 2004 May; 26(5):447-55. PubMed ID: 15122662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inferior outcomes in immunosuppressed patients with high-risk cutaneous squamous cell carcinoma of the head and neck treated with surgery and radiation therapy.
    Manyam BV; Gastman B; Zhang AY; Reddy CA; Burkey BB; Scharpf J; Alam DS; Fritz MA; Vidimos AT; Koyfman SA
    J Am Acad Dermatol; 2015 Aug; 73(2):221-7. PubMed ID: 26028524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Adjuvant Radiation Therapy With Survival in Patients With Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck.
    Harris BN; Pipkorn P; Nguyen KNB; Jackson RS; Rao S; Moore MG; Farwell DG; Bewley AF
    JAMA Otolaryngol Head Neck Surg; 2019 Feb; 145(2):153-158. PubMed ID: 30570645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes in Advanced Head and Neck Cancer Treated with Up-front Neck Dissection prior to (Chemo)Radiotherapy.
    Elicin O; Albrecht T; Haynes AG; Bojaxhiu B; Nisa L; Caversaccio M; Dal Pra A; Schmücking M; Aebersold DM; Giger R
    Otolaryngol Head Neck Surg; 2016 Feb; 154(2):300-8. PubMed ID: 26450749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent Radiotherapy With Cetuximab or Platinum-based Chemotherapy for Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck.
    Lu SM; Lien WW
    Am J Clin Oncol; 2018 Jan; 41(1):95-99. PubMed ID: 26353121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival outcomes with concurrent chemoradiation for elderly patients with locally advanced head and neck cancer according to the National Cancer Data Base.
    Amini A; Jones BL; McDermott JD; Serracino HS; Jimeno A; Raben D; Ghosh D; Bowles DW; Karam SD
    Cancer; 2016 May; 122(10):1533-43. PubMed ID: 26969811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical resection is necessary to maximize tumor control in function-preserving, aggressive chemoradiation protocols for advanced squamous cancer of the head and neck (stage III and IV).
    Wanebo H; Chougule P; Ready N; Safran H; Ackerley W; Koness RJ; McRae R; Nigri P; Leone L; Radie-Keane K; Reiss P; Kennedy T
    Ann Surg Oncol; 2001 Sep; 8(8):644-50. PubMed ID: 11569779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative simultaneous fractionated cisplatin and radiation therapy in the treatment of advanced operable stage III and IV squamous cell carcinoma of the head and neck.
    Davis MA; Tyrrell J; Slotman GJ; Sudhindra R; Sachdeva K; Fanelle J; Smith G; Wurzer JV; Cassir J; Nazha NT;
    Am J Surg; 2015 Mar; 209(3):575-9. PubMed ID: 25557972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Head and neck squamous cell carcinoma in elderly patients: a long-term retrospective review of 273 cases.
    Sarini J; Fournier C; Lefebvre JL; Bonafos G; Van JT; Coche-Dequéant B
    Arch Otolaryngol Head Neck Surg; 2001 Sep; 127(9):1089-92. PubMed ID: 11556858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcomes after multidisciplinary management of T3 laryngeal squamous cell carcinomas: Improved functional outcomes and survival with modern therapeutic approaches.
    Fuller CD; Mohamed AS; Garden AS; Gunn GB; Mulcahy CF; Zafereo M; Phan J; Lai SY; Lewin JS; Hutcheson KA; Frank SJ; Beadle BM; Morrison WH; El-Naggar AK; Kocak-Uzel E; Ginsberg LE; Kies MS; Weber RS; Rosenthal DI
    Head Neck; 2016 Dec; 38(12):1739-1751. PubMed ID: 27466789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative concurrent chemotherapy and radiotherapy for high-risk cutaneous squamous cell carcinoma of the head and neck.
    Tanvetyanon T; Padhya T; McCaffrey J; Kish JA; Deconti RC; Trotti A; Rao NG
    Head Neck; 2015 Jun; 37(6):840-5. PubMed ID: 24623654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose or low-dose cisplatin concurrent with radiotherapy in locally advanced head and neck squamous cell cancer.
    Chang CL; Yuan KS; Wu SY
    Head Neck; 2017 Jul; 39(7):1364-1370. PubMed ID: 28370614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Definitive chemoradiotherapy with carboplatin for squamous cell carcinoma of the head and neck.
    Nagasaka M; Zaki M; Issa M; Kim H; Abrams J; Sukari A
    Laryngoscope; 2017 Oct; 127(10):2260-2264. PubMed ID: 28271529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.